Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
405 INR | +1.76% | -4.10% | -0.09% |
04-30 | Granules Pharmaceuticals Arm Gets US FDA's Approval for Generic Drug for Gout Flares | MT |
04-15 | Granules India Gets Zero Observation from US FDA After Inspection of Visakhapatnam, India Unit | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.09% | 1.15B | |
+29.24% | 684B | |
+29.45% | 568B | |
-3.85% | 361B | |
+18.45% | 329B | |
+4.47% | 284B | |
+16.06% | 240B | |
+9.34% | 208B | |
-7.08% | 200B | |
+7.71% | 166B |
- Stock Market
- Equities
- GRANULES Stock
- News Granules India Limited
- Transcript : Granules India Limited, Q2 2024 Earnings Call, Nov 09, 2023